Vaxcyte, Inc. (PCVX) Discusses Top Line Results From OPUS-1 Phase 3 Trial of VAX-31 Pneumococcal Vaccine Candidate – Slideshow
Vaxcyte, Inc. (PCVX) Discusses Top Line Results From OPUS-1 Phase 3 Trial of VAX-31 Pneumococcal Vac[……] Read More
AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine
Thursday 28 May 2026 6:06 pm The Access to Advanced Health Institute[……] Read More
SA to build Africa’s first full vaccine facility
Is SA creating a two-tier workforce? Labour reform raises alarm over exec protection. How criminals[……] Read More